Abstract:Background: Cancer is one of the most common reasons for mortality in the world. A continuous effort to develop effective anti-cancer drugs with minimum side effects has become necessary. The use of small-molecule drugs has revolutionized cancer research by inhibiting cancer cell survival and proliferation. Quinazolines are a class of bioactive heterocyclic compounds with active pharmacophores in several anti-cancer drugs. Such small molecule inhibitors obstruct the significant signals responsible for cancer cell development, thus blocking these cell signals to prevent cancer development and spread. Objective: In the current study, novel quinazoline derivatives structurally similar to erlotinib were synthesized and explored as novel anti-cancer agents. Methods: All the synthesized molecules were confirmed by spectroscopic techniques like 1 H NMR, 13 C NMR, and ESI-MS. Various techniques were applied to study the protein-drug interaction, DFT analysis, Hirshfeld surface, and target prediction. The molecules were screened in vitro for their anti-cancer properties against 60 human tumor cell lines. The growth inhibitory properties of a few compounds were studied against the MCF7 breast cancer cell line. Results: The activity of compounds 9f, 9o, and 9s were found to be active. However, compound 9f is more active when compared with other compounds. Conclusion: Some synthesized compounds were active against different cancer cell lines. The in-vitro study results were found to be in agreement with the predictions from in-silico data. The selected molecules were further subjected to get the possible mechanism of action against different cancer cells.

Synthesis and cytotoxicity studies of novel N-arylbenzo[h]quinazolin-2-amines

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole

Novel 2-amino-1,4-naphthoquinone hybrids: Design, synthesis, cytotoxicity evaluation and in silico studies

Design and synthesis of BMH-21-like quinazolinone derivatives as potential anti-cancer agents

The Effective Synthesis of New Benzoquinoline Derivatives as Small Molecules with Anticancer Activity

Synthesis and Biological Evaluation of Novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline Derivatives As Potent Antitumor Agents.

Synthesis, cytotoxic and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety.

Syntheses and Cytotoxicities of Quinazolinone-Based Conjugates

Synthesis of 8-methyl-2-phenylquinazolin-4(3 H )-ones derived Schiff's bases: Spectroscopic properties, SAR, docking approaches and their anticancer and antimicrobial activity

Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies

Synthesis of Polyhalo 2-Aryl-4-aminoquinazolines and 3-Amino-indazoles As Anti-Cancer Agents

Synthesis and Antiproliferative Activity Studies on 2-Substitued Aniline Quinazoline Derivatives

Synthesis and anticancer activity of novel quinazolinone-based rhodanines

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Synthesis of Novel Quinazolin-4-One Derivatives Bearing Benzo[C]-Chromen-6-One and Their Anti-Tumor and Antimicrobial Activities

Synthesis and Evaluation of 4(3H) -Quinazolinone Derivatives Bearing Aromatic Amine Side Chains As Antitumor Agents

Synthesis and Anticancer Activity of Some Novel 2-Phenazinamine Derivatives.

Synthesis of Substituted Benzylamino‐ and Heterocyclylmethylamino Carbodithioate Derivatives of 4‐(3h)‐quinazolinone and Their Cytotoxic Activity.

Synthesis of 4-Hydroxyquinolines as Potential Cytotoxic Agents

Design, Synthesis, and Molecular Docking Studies of New Quinoline-Thiazole Hybrids, Potential Leads in the Development of Novel Antileukemic Agents

Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety